# To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery

> **NCT05145647** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** Add-on Brachytherapy
- **DEVICE:** "BRAXX" Esophageal Brachytherapy Applicator

## Key facts

- **NCT ID:** NCT05145647
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-30
- **Primary completion:** 2026-10-18
- **Final completion:** 2026-10-18
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05145647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05145647, "To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05145647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*